| Counting on natural products for drug design T Rodrigues, D Reker, P Schneider, G Schneider Nature chemistry 8 (6), 531-541, 2016 | 1182 | 2016 |
| Rethinking drug design in the artificial intelligence era P Schneider, WP Walters, AT Plowright, N Sieroka, J Listgarten, ... Nature reviews drug discovery 19 (5), 353-364, 2020 | 659 | 2020 |
| Generative Recurrent Networks for De Novo Drug Design A Gupta, AT Müller, BJH Huisman, JA Fuchs, P Schneider, G Schneider Molecular informatics 37 (1-2), 1700111, 2018 | 540 | 2018 |
| Development of a virtual screening method for identification of “frequent hitters” in compound libraries O Roche, P Schneider, J Zuegge, W Guba, M Kansy, A Alanine, ... Journal of medicinal chemistry 45 (1), 137-142, 2002 | 346 | 2002 |
| De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks G Schneider, ML Lee, M Stahl, P Schneider Journal of computer-aided molecular design 14, 487-494, 2000 | 337 | 2000 |
| Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus D Reker, T Rodrigues, P Schneider, G Schneider Proceedings of the National Academy of Sciences 111 (11), 4067-4072, 2014 | 231 | 2014 |
| Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation M Wichert, N Krall, W Decurtins, RM Franzini, F Pretto, P Schneider, ... Nature chemistry 7 (3), 241-249, 2015 | 212 | 2015 |
| Scaffold‐hopping: how far can you jump? G Schneider, P Schneider, S Renner QSAR & Combinatorial Science 25 (12), 1162-1171, 2006 | 176 | 2006 |
| De novo design at the edge of chaos: Miniperspective P Schneider, G Schneider Journal of medicinal chemistry 59 (9), 4077-4086, 2016 | 175 | 2016 |
| Chemically advanced template search (CATS) for scaffold-hopping and prospective target prediction for ‘orphan’molecules M Reutlinger, CP Koch, D Reker, N Todoroff, P Schneider, T Rodrigues, ... Molecular informatics 32 (2), 133, 2013 | 162 | 2013 |
| Collection of bioactive reference compounds for focused library design P Schneider, G Schneider QSAR & Combinatorial Science 22 (7), 713-718, 2003 | 159 | 2003 |
| Virtual screening for bioactive molecules by evolutionary de novo design G Schneider, O Clément‐Chomienne, L Hilfiger, P Schneider, S Kirsch, ... Angewandte Chemie International Edition 39 (22), 4130-4133, 2000 | 157 | 2000 |
| Self-organizing maps in drug discovery: compound library design, scaffold-hopping, repurposing P Schneider, Y Tanrikulu, G Schneider Current medicinal chemistry 16 (3), 258-266, 2009 | 134 | 2009 |
| Glossary of terms used in combinatorial chemistry D Maclean, JJ Baldwin, VT Ivanov, Y Kato, A Shaw, P Schneider, ... Pure and Applied Chemistry 71 (12), 2349-2365, 1999 | 134 | 1999 |
| Privileged structures revisited P Schneider, G Schneider Angewandte Chemie International Edition 56 (27), 7971-7974, 2017 | 133 | 2017 |
| Revealing the macromolecular targets of complex natural products D Reker, AM Perna, T Rodrigues, P Schneider, M Reutlinger, B Mönch, ... Nature chemistry 6 (12), 1072-1078, 2014 | 133 | 2014 |
| Comparison of correlation vector methods for ligand-based similarity searching U Fechner, L Franke, S Renner, P Schneider, G Schneider Journal of computer-aided molecular design 17, 687-698, 2003 | 131 | 2003 |
| Accessing new chemical entities through microfluidic systems T Rodrigues, P Schneider, G Schneider Angewandte Chemie International Edition 53 (23), 5750-5758, 2014 | 104 | 2014 |
| The interaction between dispersal, the Allee effect and scramble competition affects population dynamics R Etienne, B Wertheim, L Hemerik, P Schneider, J Powell Ecological Modelling 148 (2), 153-168, 2002 | 102 | 2002 |
| Voyages to the (un) known: adaptive design of bioactive compounds G Schneider, M Hartenfeller, M Reutlinger, Y Tanrikulu, E Proschak, ... Trends in biotechnology 27 (1), 18-26, 2009 | 101 | 2009 |
Gisbert SchneiderETH Zurich在 ethz.ch 的电子邮件经过验证
